Page 25 - Development Command News Today

Collaboration with U.S. Army seeks to improve medic training and certification Triage care on the battlefield requires split-second decision-making and proficiency in providing first aid. Correctly applying a tourniquet or inserting an intubation tube before a patient is evacuated to a hospital could save lives. To improve training for the field medics responsible for this level of care, researchers at Rensselaer Polytechnic Institute will team up with researchers from the United States Army Re...

ABBOTT PARK, Ill., January 19, 2021 /3BL Media/ -- Abbott (NYSE: ABT) has received 510(k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions. The test will run on Abbotts handheld i-STAT™ Alinity™ platform. Tests results are available within 15 minutes after plasma is placed in the test cartridge. TBIs, including concussions, are an alteration in brain function caused...

GSDF staffer accused of molesting school girl By Tokyo Reporter Staff on January 16, 2021 TOKYO (TR) – Tokyo Metropolitan Police have arrested a 35-year-old Ground Self-Defense Force member over the alleged molestation of an elementary school girl earlier this month, reports the Sankei Shimbun (Jan. 15). At around 2:00 p.m. on January 11, Takuya Kubo, a major in the Ground Research and Development Command, allegedly abducted the girl, a fifth-year student, from an event in Chiyoda Ward. Kubo...

6 FORT DETRICK, MD – The U.S. Army Medical Materiel Development Activity, in partnership with BioFire Defense LLC, announced U.S. Food and Drug Administration marketing approvals for the Next Generation Diagnostics System Increment 1 Infectious Disease Panel, also known as the Global Fever Panel, and the associated External Control Kit. The FilmArray® Global Fever Panel is a commercially available single-use, fully enclosed test for use with the BioFire® FilmArray 2.0 instru...

6 Following a year of intense dedication to the U.S. Army Medical Research and Development Command’s sprawling efforts to combat the novel coronavirus pandemic, LTC Michelle Colacicco-Mayhugh has been named a 2021 Heroes of Military Medicine award winner. The award, which honors outstanding contributions by individuals dedicated to advancing the ideals and reach of military medicine, is presented by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc....

Abbott  has received 510 clearance for the first rapid handheld traumatic brain injury blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions. The test will run on Abbott's handheld i-STAT™ Alinity™ platform. Tests results are available within 15 minutes after plasma is placed in the test cartridge. TBIs, including concussions, are an alteration in brain ...

New testing system can detect TBI in wounded soldiers Follow Us Question of the Day By Mike Glenn - The Washington Times - Monday, January 11, 2021 More than 400,000 military personnel sustained traumatic brain injuries as a result of combat or training accidents between 2000 and 2019 and now the Food and Drug Administration has approved a blood test that can rapidly detect early signs of the condition that has ...

Share Last New Year’s Eve, the first COVID-19 case was reported in Wuhan, China. Since then, the virus has spread all over the world. Today, more than 70 million coronavirus cases and nearly 1.6 million deaths associated with the virus have been reported, according to the World Health Organization.  By February, health systems were quickly responding and rethinking their care-delivery model. Over the last year,  MobiHealthNews has closely reported on how providers are using digital he...

Startup gets Army funding to test wearable monitor for early Covid-19 detection Remote monitoring startup BioIntelliSense and Royal Phillips received $2.8 million to test BioIntelliSense’s device for the early detection of Covid-19 symptoms. The startup received FDA clearance for its small, adhesive monitoring device last year. Shares1 BioIntelliSense makes small, adhesive sensors that can monitor a patient’s vital signs. Photo credit: BioIntelliSense Remote-monitoring startup BioIntelliSe...

News Category Global Banking & Finance Reviews Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection December 22, 2020 Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receiv...